Abeona Therapeutics (ABEO) Other Operating Expenses (2011 - 2026)

Abeona Therapeutics' Other Operating Expenses history runs 15 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Other Operating Expenses changed N/A year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $6.1 million (changed N/A YoY), while the FY2025 annual figure was $3.4 million, changed N/A from the prior year.
• Other Operating Expenses was $2.7 million for Q1 2026 at Abeona Therapeutics, down from $2.8 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $2.8 million in Q4 2025 to a low of -$1.1 million in Q2 2022.
• Historically, Other Operating Expenses has averaged $634454.5 across 4 years, with a median of $403000.0 in 2023.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses plunged 733.33% in 2022, then jumped 6816.67% in 2023.
• A 4-year view of Other Operating Expenses shows it stood at $1.0 million in 2022, then slumped by 97.14% to $30000.0 in 2023, then soared by 9356.67% to $2.8 million in 2025, then fell by 4.97% to $2.7 million in 2026.
• The last three Other Operating Expenses figures came in at $2.7 million (Q1 2026), $2.8 million (Q4 2025), and $488000.0 (Q3 2025), per Business Quant data.